SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Natural Resource Stocks -- Ignore unavailable to you. Want to Upgrade?


To: RealMuLan who wrote (306)9/17/2003 7:36:48 PM
From: Stephen O  Read Replies (3) | Respond to of 108728
 
re drug companies. There was a story yesterday in the Vancouver Sun about a study performed by a professor from UBC, a Jim Wright, who states that people who have not had heart problems should not take Statin drugs to reduce cholesterol. Sure if you have had a heart attack then take them. The study shows that as many problems are caused to people's health by the drugs than the benefits to be gained from lowering cholesterol. I suspect that if this study gets out and is believed the rate of Lipitor use etc could get cut in half. What will that do to Pfizer's profits. Unfortunately the Vancouver Sun web site is the sh*ts and I can't get the story on line. I will be contacting this professor myself soon.



To: RealMuLan who wrote (306)9/18/2003 1:17:14 AM
From: Jim Willie CB  Read Replies (1) | Respond to of 108728
 
numerous examples heading to India and China
but a new trend for drug companies would be absolutely huge
we have an aging poopulation
my parents spend $100's each month of drugs
e.g. prostate, thyroid, etc

if Medicare prescription drugs goes to Canada, that is huge
many have considered drug sector as a captive sector
this may not be so

/ jim